Search by keywords: and/or Search by cancer type: Thoracic-Lung Cancer [5]--Lung Cancer, Non-Small Cell [62]---Lung Adenocarcinoma [2]---Other [4]--Lung Cancer, Small Cell [8] Narrow your choices Trial phase: - Any -Pilot (small research study)Phase I (phase 1)Phase I/II (phases 1 and 2 combined)Phase II (phase 2)Phase II/III (phases 2 and 3 combined)Phase III (phase 3)Phase IV (phase 4)N/APhase III/IV (phases 3 and 4 combined)Phase 0 (very small research study) Reset 72 Clinical Trials found A Phase 2 Study of Chemoembolization in People With Non-Small Cell Lung Cancer Researchers are doing this study to learn if lung chemoembolization is safe and works well in people with lung cancer. The people in this study have non-small cell lung cancer that keeps growing after chemotherapy. Moreover, it cannot be cured with surgery or radiation therapy. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 2 Study of JNJ-90301900 and Chemoradiation Followed by Durvalumab in People With Stage 3 Lung Cancer [NOTE THAT ASTRAZENECA, THE MAKER OF DURVALUMAB, REQUESTS WE DO NOT SHARE ANY INFO THAT IS NOT ON CLINICALTRIALS.GOV] New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 2 Study of Sotorasib to Treat Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer The purpose of this study is to see how well sotorasib works in people with advanced lung cancer. The people in this study have non-small cell lung cancer (NSCLC) with a mutation (change) in the KRAS G12C gene. This mutation can cause cancer cells to grow. In addition, the people in this study have not received treatment for their cancer since it became advanced. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 2 Study of Stereotactic Radiosurgery and Standard Treatment in People With EGFR-Positive Lung Cancer That Has Spread to the Brain Researchers want to see if giving stereotactic radiosurgery (SRS) after osimertinib is better than osimertinib alone for advanced lung cancer. The people in this study have non-small cell lung cancer (NSCLC) that metastasized (spread) to the brain. Their cancers have a mutation (change) in the EGFR gene, and they are taking or planning to take osimertinib. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 2 Study of Targeted Treatment for MET Exon 14 Skipping-Positive Advanced Non-Small Cell Lung Cancer Researchers are assessing tepotinib with or without ramucirumab in people with non-small cell lung cancer (NSCLC). The people in this study have NSCLC that has metastasized (spread) or recurred (came back) after treatment. Their cancers also have a genetic change called the MET exon 14 skipping mutation. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 2 Study of Zipalertinib in People With Advanced Non-Small Cell Lung Cancer The purpose of this study is to see how well zipalertinib works to treat advanced lung cancer. The people in this study have non-small cell lung cancer (NSCLC) that has spread. The cancer also has a mutation (change) in the EGFR gene. When people have an EGFR mutation, the EGFR protein on their cells can trigger cancer growth. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 3 Study Assessing the Addition of High-Dose, Targeted Radiation to the Usual Treatment for Inoperable Non-Small Cell Lung Cancer Researchers want to see if giving additional radiation therapy to standard treatment helps people with lung cancer to live longer. The people in this study have non-small cell lung cancer (NSCLC) that cannot be removed with surgery (inoperable cancer). The standard treatment includes image-guided radiation therapy (IGRT), chemotherapy, and immunotherapy with durvalumab.  New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 3 Study Comparing Neladalkib (NVL-655) With Alectinib in People With Advanced Non-Small Cell Lung Cancer In addition, their cancers have a fusion (change) in the ALK gene. The fusion gene makes a protein that promotes cancer growth and survival. This type of cancer is called ALK-positive NSCLC. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 3 Study Comparing Proton Craniospinal Radiation Therapy With the Usual Radiation Therapy for Leptomeningeal Metastasis Breast cancer and non-small cell lung cancer (NSCLC) can spread to the cerebrospinal fluid-filled space around the brain and spinal cord. This is called leptomeningeal metastasis (LM). The effects of LM on the nervous system can be very serious. New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau A Phase 3 Study of Dato-DXd With or Without Osimertinib Versus Chemotherapy for People With Non-Small Cell Lung Cancer If you join this study, you will be randomly assigned to get one of these treatments: New York City, Commack, Basking Ridge, Westchester, Monmouth, Bergen, Nassau Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Next page Next › Last page Last »